Henrik Cederleuf

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

American journal of hematology

Leukemia & lymphoma

Blood advances

British journal of haematology

Skånes universitetssjukhus Lund

Lunds universitet Medicinska fakulteten (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Skånes universitetssjukhus Lund Mar 11 2013

Sweden

ST-läkare :: Onkologi

Education History

Lunds universitet Medicinska fakulteten Nov 01 2015

Sweden

PHD :: Oncology & Pathology

Publications

Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology 98 (3) (2023)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology 98 (3) (2023)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology (2023)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology 98 (3) (2023)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology 98 (3) (2023)
Monica Mead, Henrik Cederleuf, Maja Björklund, Xiaoyan Wang, Thomas Relander, Mats Jerkeman, Daria Gaut, Sarah Larson, Fredrik Ellin
Impact of comorbidity in elderly patients with peripheral T-cell lymphoma: an international retrospective analysis of 891 patients. Blood advances (2021)
Henrik Cederleuf, Lasse Hjort Jakobsen, Fredrik Ellin, Peter de Nully Brown, Thomas Stauffer Larsen, Martin Bøgsted, Thomas Relander, Mats Jerkeman, Tarec Christoffer El-Galaly
Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study. Leukemia & lymphoma 58 (12) (2017)
Henrik Cederleuf, Martin Bjerregård Pedersen, Mats Jerkeman, Thomas Relander, Francesco d'Amore, Fredrik Ellin
The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study. British journal of haematology 178 (5) (2017)

Henrik Cederleuf.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Henrik Cederleuf